Filts Y, Litman RE, Martinez J, Anta L, et al. Corrigendum to "Long-term efficacy and safety of once-monthly Risperidone ISM(R) in the treatment of schizophrenia: Results from a 12-month open-label extension study" [Schizophr. Res. 239 (2022) 83-91]. Schizophr Res 2022;246:258-259.
PMID: 35853294